Pfizer 3Q 3Q Revenues: $11.6 billion (-3%) 3Q Earnings: $2.9 billion (+26%) YTD Revenues: $33.5 billion (-7%) YTD Earnings: $7.9 billion (flat) Comments: Total pharmaceutical sales in the quarter were $10.7 billion (-3%). Primary Care sales were down 4% to $5.5 billion. Specialty Care sales were up 3% to $1.6 billion. Oncology revenue was $371 million (-5%). Established Products revenue was $1.6 billion (-12%) and Emerging Markets revenue was $1.6 billion (-4%). U.S. revenues were...